These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

128 related items for PubMed ID: 8280488

  • 1. The prognostic value of epidermal growth factor receptors, determined by both immunohistochemistry and ligand binding assays, in primary epithelial ovarian cancer: a pilot study.
    van der Burg ME, Henzen-Logmans SC, Foekens JA, Berns EM, Rodenburg CJ, van Putten WL, Klijn JG.
    Eur J Cancer; 1993; 29A(14):1951-7. PubMed ID: 8280488
    [Abstract] [Full Text] [Related]

  • 2. Receptors for hormones and growth factors and (onco)-gene amplification in human ovarian cancer.
    Berns EM, Klijn JG, Henzen-Logmans SC, Rodenburg CJ, van der Burg ME, Foekens JA.
    Int J Cancer; 1992 Sep 09; 52(2):218-24. PubMed ID: 1325950
    [Abstract] [Full Text] [Related]

  • 3. The prognostic value of epidermal growth factor receptor (EGF-R) in primary breast cancer: results of a 10 year follow-up study.
    Klijn JG, Look MP, Portengen H, Alexieva-Figusch J, van Putten WL, Foekens JA.
    Breast Cancer Res Treat; 1994 Jan 09; 29(1):73-83. PubMed ID: 8018964
    [Abstract] [Full Text] [Related]

  • 4. Ki-67 staining in benign, borderline, malignant primary and metastatic ovarian tumors: correlation with steroid receptors, epidermal-growth-factor receptor and cathepsin D.
    Henzen-Logmans SC, Fieret EJ, Berns EM, van der Burg ME, Klijn JG, Foekens JA.
    Int J Cancer; 1994 May 15; 57(4):468-72. PubMed ID: 8181851
    [Abstract] [Full Text] [Related]

  • 5. [Immunohistochemical detection of epidermal growth factor receptor (EGF-R) in paraffin sections of breast carcinoma tissue: correlation and clinical significance].
    Beckmann MW, Tutschek B, Göhring UJ, Engels K, Picard FK, Scharl A, Niederacher D, Schnürch HG.
    Geburtshilfe Frauenheilkd; 1995 May 15; 55(5):258-65. PubMed ID: 7607382
    [Abstract] [Full Text] [Related]

  • 6. Simultaneous estimation of epidermal growth factor receptors and steroid receptors in a series of 136 resectable primary breast tumors.
    Cappelletti V, Brivio M, Miodini P, Granata G, Coradini D, Di Fronzo G.
    Tumour Biol; 1988 May 15; 9(4):200-11. PubMed ID: 3420376
    [Abstract] [Full Text] [Related]

  • 7. Prognostic value of pS2 protein and receptors for epidermal growth factor (EGF-R), insulin-like growth factor-1 (IGF-1-R) and somatostatin (SS-R) in patients with breast and ovarian cancer.
    Foekens JA, van Putten WL, Portengen H, Rodenburg CJ, Reubi JC, Berns PM, Henzen-Logmans SC, van der Burg ME, Alexieva-Figusch J, Klijn JG.
    J Steroid Biochem Mol Biol; 1990 Dec 20; 37(6):815-21. PubMed ID: 2178364
    [Abstract] [Full Text] [Related]

  • 8. Oestrogen and progesterone receptor content as a prognostic factor in advanced epithelial ovarian carcinoma.
    Sevelda P, Denison U, Schemper M, Spona J, Vavra N, Salzer H.
    Br J Obstet Gynaecol; 1990 Aug 20; 97(8):706-12. PubMed ID: 2400748
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Epidermal growth factor receptor in human breast cancer: correlation with steroid hormone receptors and axillary lymph node involvement.
    Battaglia F, Scambia G, Rossi S, Panici PB, Bellantone R, Polizzi G, Querzoli P, Negrini R, Iacobelli S, Crucitti F.
    Eur J Cancer Clin Oncol; 1988 Nov 20; 24(11):1685-90. PubMed ID: 3061825
    [Abstract] [Full Text] [Related]

  • 15. Receptors for epidermal growth factor and steroid hormones in primary laryngeal tumors.
    Scambia G, Panici PB, Battaglia F, Ferrandina G, Almadori G, Paludetti G, Maurizi M, Mancuso S.
    Cancer; 1991 Mar 01; 67(5):1347-51. PubMed ID: 1991297
    [Abstract] [Full Text] [Related]

  • 16. Occurrence of epidermal growth factor receptors in benign and malignant ovarian tumors and normal ovarian tissues: an immunohistochemical study.
    Henzen-Logmans SC, van der Burg ME, Foekens JA, Berns PM, Brussée R, Fieret JH, Klijn JG, Chadha S, Rodenburg CJ.
    J Cancer Res Clin Oncol; 1992 Mar 01; 118(4):303-7. PubMed ID: 1315781
    [Abstract] [Full Text] [Related]

  • 17. Estrogen receptors (ER) in human breast cancer. The significance of a new prognostic factor based on both ER protein and ER mRNA contents.
    Gotteland M, May E, May-Levin F, Contesso G, Delarue JC, Mouriesse H.
    Cancer; 1994 Aug 01; 74(3):864-71. PubMed ID: 7913659
    [Abstract] [Full Text] [Related]

  • 18. A simplified immuno-enzymetric assay of the epidermal growth factor receptor in breast tumors: evaluation in 282 cases.
    Grimaux M, Mady E, Remvikos Y, Laine-Bidron C, Magdelenat H.
    Int J Cancer; 1990 Feb 15; 45(2):255-62. PubMed ID: 2406203
    [Abstract] [Full Text] [Related]

  • 19. [Epidermal growth factor receptor in human breast cancer: correlation with steroid receptors, tumor stage, grading and menopausal status].
    Speiser P, Sliutz G, Zeillinger R, Czerwenka K, Jakesz R, Knogler W, Kury F, Reiner A, Sevelda P, Schneeberger C.
    Geburtshilfe Frauenheilkd; 1992 Jun 15; 52(6):355-9. PubMed ID: 1634099
    [Abstract] [Full Text] [Related]

  • 20. EGFR and steroid receptors in ovarian carcinoma: comparison with prognostic parameters and outcome of patients.
    Fischer-Colbrie J, Witt A, Heinzl H, Speiser P, Czerwenka K, Sevelda P, Zeillinger R.
    Anticancer Res; 1997 Jun 15; 17(1B):613-9. PubMed ID: 9066588
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.